GenSight Biologics (GSGTF) Short Interest Ratio & Short Volume → Central Banks Preparing for US Dollar Collapse? (From Behind the Markets) (Ad) Free GSGTF Stock Alerts $0.45 0.00 (0.00%) (As of 03/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort Interest GenSight Biologics Short Interest DataCurrent Short Volume6,400 sharesPrevious Short Volume0 sharesChange Vs. Previous Month+∞Dollar Volume Sold Short$1.92Short Interest Ratio / Days to Cover16.0Last Record DateNovember 15, 2023Today's Trading Volume0 sharesAverage Trading Volume583 sharesToday's Volume Vs. Average0% Short Selling GenSight Biologics ? Sign up to receive the latest short interest report for GenSight Biologics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGSGTF Short Interest Over TimeGSGTF Days to Cover Over TimeGSGTF Percentage of Float Shorted Over Time Ad Behind the MarketsCentral Banks Preparing for US Dollar Collapse?China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.Find out how you can protect yourself now >>> GenSight Biologics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/15/20236,400 shares $1.92 No ChangeN/A16 $0.00 7/15/20231,000 shares $755.00 No ChangeN/A10 $0.76 6/30/20231,000 shares $800.00 -9.1%N/A10 $0.80 6/15/20231,100 shares $880.00 +10.0%N/A0 $0.80 5/31/20231,000 shares $800.00 No ChangeN/A0 $0.80 5/15/20231,000 shares $800.00 No ChangeN/A5 $0.80 Get the Latest News and Ratings for GSGTF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GenSight Biologics and its competitors with MarketBeat's FREE daily newsletter. 2/15/202310,200 shares $31,620.00 -2.9%N/A0 $3.10 1/31/202310,500 shares $32,550.00 No ChangeN/A0 $3.10 1/15/202310,500 shares $32,550.00 No ChangeN/A52.5 $3.10 12/30/202210,500 shares $33,075.00 No ChangeN/A105 $3.15 12/15/202210,500 shares $33,075.00 No ChangeN/A105 $3.15 11/30/202210,500 shares $33,075.00 No ChangeN/A0 $3.15 11/15/202210,500 shares $33,075.00 No ChangeN/A0 $3.15 10/31/202210,500 shares $33,075.00 No ChangeN/A105 $3.15 10/15/202210,500 shares $36,750.00 No ChangeN/A52.5 $3.50 9/30/202210,500 shares $36,750.00 No ChangeN/A0 $3.50 9/15/202210,500 shares $36,750.00 No ChangeN/A0 $3.50 8/31/202210,500 shares $36,750.00 No ChangeN/A2.4 $3.50 8/15/202210,500 shares $49,875.00 No ChangeN/A105 $4.75 7/31/202210,500 shares $49,875.00 No ChangeN/A0 $4.75 7/15/202210,500 shares $49,875.00 No ChangeN/A0 $4.75 6/30/202210,500 shares $49,875.00 No ChangeN/A0 $4.75 6/15/202210,500 shares $49,875.00 +1.0%N/A0 $4.75 5/31/202210,400 shares $49,400.00 -11.9%N/A0 $4.75 5/15/202211,800 shares $56,050.00 +13.5%N/A0 $4.75 4/30/202210,400 shares $49,400.00 No ChangeN/A104 $4.75 4/15/202210,400 shares $49,400.00 +2.0%N/A0 $4.75 3/31/202210,200 shares $48,450.00 No ChangeN/A3.8 $4.75 3/15/202210,200 shares $48,450.00 No ChangeN/A0.5 $4.75 2/28/202210,200 shares $48,450.00 No ChangeN/A0 $4.75 2/15/202210,200 shares $48,450.00 No ChangeN/A5.7 $4.75 1/31/202210,200 shares $45,900.00 No ChangeN/A4.4 $4.50 1/15/202210,200 shares $68,850.00 No ChangeN/A0 $6.75 11/30/2021100 shares $675.00 No ChangeN/A0.1 $6.75 11/15/2021100 shares $725.86 No ChangeN/A0.3 $7.26 10/29/2021100 shares $845.00 No ChangeN/A0 $8.45 9/15/2021100 shares $935.00 No ChangeN/A0.5 $9.35 8/31/2021100 shares $900.00 No ChangeN/A0.1 $9.00 7/30/202132,900 shares $200,693.29 -66.6%N/A14.3 $6.10 7/15/202198,400 shares $851,160.00 -42.2%N/A196.8 $8.65Central Banks Preparing for US Dollar Collapse? (Ad)China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.Find out how you can protect yourself now >>> GSGTF Short Interest - Frequently Asked Questions What is GenSight Biologics' current short interest? Short interest is the volume of GenSight Biologics shares that have been sold short but have not yet been covered or closed out. As of November 15th, traders have sold 6,400 shares of GSGTF short. Learn More on GenSight Biologics' current short interest. What is a good short interest ratio for GenSight Biologics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GSGTF shares currently have a short interest ratio of 16.0. Learn More on GenSight Biologics's short interest ratio. Is GenSight Biologics' short interest increasing or decreasing? GenSight Biologics saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 6,400 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Co. ($7.24 billion), T-Mobile US, Inc. ($4.02 billion), Charter Communications, Inc. ($3.72 billion), Occidental Petroleum Co. ($2.80 billion), Lululemon Athletica Inc. ($2.48 billion), Coinbase Global, Inc. ($2.38 billion), Tractor Supply ($2.35 billion), Rivian Automotive, Inc. ($1.79 billion), Royal Caribbean Cruises Ltd. ($1.73 billion), and Moderna, Inc. ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short GenSight Biologics stock? Short selling GSGTF is an investing strategy that aims to generate trading profit from GenSight Biologics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against GenSight Biologics? A short squeeze for GenSight Biologics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GSGTF, which in turn drives the price of the stock up even further. How often is GenSight Biologics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GSGTF, twice per month. The most recent reporting period available is November, 15 2023. More Short Interest Resources from MarketBeat Related Companies: ATNFW Short Interest Data TRSBF Short Interest Data ABCZF Short Interest Data AGNPF Short Interest Data DRTSW Short Interest Data APLMW Short Interest Data ARTLW Short Interest Data ASPHF Short Interest Data ASCLF Short Interest Data AVCTF Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:GSGTF) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 Media“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyOnly a fool would buy Nvidia today… Porter & CompanyMost important medical advance in 100 yearsThe Oxford ClubFed launches fourth dollar overhaulStansberry Research